Successful resolution of inflammation and increased regulatory T cells in sirolimus-treated post-transplant allograft hepatitis

Pediatric Transplantation

Volumn 16, Issue 2, 2012, Pages 165-175

  Ekong, Udeme D ^a   Mathew, James ^b   Melin Aldana, Hector ^a   Wang, Deli ^c   Alonso, Estella M ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHILDREN S MEMORIAL RESEARCH CENTER   (United States)

Author keywords

chronic hepatitis; pediatric liver transplantation; regulatory T cells

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; LIVER ENZYME; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTTRANSPLANT ALLOGRAFT HEPATITIS; POSTTRANSPLANT ALLOGRAFT HEPATITS; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; SCHOOL CHILD;

AZATHIOPRINE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; PREDNISONE; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TACROLIMUS; TREATMENT OUTCOME;

EID: 84863295985     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01648.x     Document Type: Article

References (37)

1. Hubscher SG,. What is the long-term outcome of the liver allograft? J Hepatol 2011: 55: 702-717.
2. Kerkar N, Hadzic N, Davies ET, et al., De-novo autoimmune hepatitis after liver transplantation. Lancet 1998: 351: 409-413. (Pubitemid 28064165)
3. Venick RS, McDiarmid SV, Farmer DG, et al., Rejection and steroid dependence: Unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis. Am J Transplant 2007: 7: 955-963. (Pubitemid 46481195)
4. Hernandez HM, Kovarik P, Whitington PF, Alonso EM,. Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr 2001: 32: 131-136. (Pubitemid 32280624)
5. Mieli-Vergani G, Vergani D,. De novo autoimmune hepatitis after liver transplantation. J Hepatol 2004: 40: 3-7. (Pubitemid 38064706)
6. Beschorner WE, Suresch DL, Shinozawa T, Santos GW, Hess AD,. Thymic immunopathology after cyclosporine: Effect of irradiation and age on medullary involution and recovery. Transplant Proc 1988: 20: 1072-1078.
7. Cooper MH, Hartman GG, Starzl TE, Fung JJ,. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc 1991: 23: 3234-3235.
8. Lotem J, Kama R, Sachs L,. Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin. Proc Natl Acad Sci U S A 1999: 96: 12016-12020. (Pubitemid 29502850)
9. Wang HG, Pathan N, Ethell IM, et al., Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999: 284: 339-343. (Pubitemid 129523456)
10. Salcedo M, Vaquero J, Banares R, et al., Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology 2002: 35: 349-356. (Pubitemid 34106374)
11. Heneghan MA, Portmann BC, Norris SM, et al., Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001: 34: 464-470. (Pubitemid 32791325)
12. Gupta P, Hart J, Millis JM, Cronin D, Brady L,. De novo hepatitis with autoimmune antibodies and atypical histology: A rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation 2001: 71: 664-668. (Pubitemid 32268071)
13. Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Uemoto S, Manabe T,. Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome. Transpl Int 2009: 22: 303-312.
14. Battaglia M, Stabilini A, Roncarolo MG,. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005: 105: 4743-4748.
15. Raimondi G, Sumpter TL, Matta BM, et al., Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. J Immunol 2010: 184: 624-636.
16. Levitsky J, Miller J, Wang E, et al., Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents. Hum Immunol 2009: 70: 146-150.
17. Hendrikx TK, Velthuis JH, Klepper M, et al., Monotherapy rapamycin allows an increase of CD4 CD25 FoxP3 T cells in renal recipients. Transpl Int 2009: 22: 884-891.
18. Batts KP, Ludwig J,. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995: 19: 1409-1417.
19. Czaja AJ,. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 2002: 8: 505-513. (Pubitemid 34619081)
20. Gao EK, Lo D, Cheney R, Kanagawa O, Sprent J,. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature 1988: 336: 176-179. (Pubitemid 18266146)
21. Wu DY, Goldschneider I,. Cyclosporin A-induced autologous graft-versus-host disease: A prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants. J Immunol 1999: 162: 6926-6933. (Pubitemid 29309422)
22. Hess AD, Tutschka PJ, Santos GW,. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF. J Immunol 1982: 128: 355-359. (Pubitemid 12207467)
23. Bucy RP, Xu XY, Li J, Huang G,. Cyclosporin A-induced autoimmune disease in mice. J Immunol 1993: 151: 1039-1050. (Pubitemid 23215769)
24. James S,. Measurement of basic immunologic characteristics of human mononuclear cells. In:, Bierer B, Strbber W, eds. Current Protocols in Immunology. Hoboken, NJ: Wiley, 2004.
25. Stenard F, Nguyen C, Cox K, et al., Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant 2009: 13: 70-80.
26. Li Y, Zhao X, Cheng D, et al., The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008: 86: 1837-1843.
27. Muthukumar T, Dadhania D, Ding R, et al., Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005: 353: 2342-2351. (Pubitemid 41713746)
28. Allan SE, Passerini L, Bacchetta R, et al., The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 2005: 115: 3276-3284. (Pubitemid 41567592)
29. Zheng Y, Rudensky AY,. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007: 8: 457-462. (Pubitemid 46605910)
30. Wang J, Ioan-Facsinay A, Van Der Voort EI, Huizinga TW, Toes RE,. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007: 37: 129-138. (Pubitemid 46128793)
31. Pillai V, Ortega SB, Wang CK, Karandikar NJ,. Transient regulatory T-cells: A state attained by all activated human T-cells. Clin Immunol 2007: 123: 18-29. (Pubitemid 46401504)
32. Brandenburg S, Takahashi T, De La Rosa M, et al., IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells. Eur J Immunol 2008: 38: 1643-1653.
33. Coenen JJ, Koenen HJ, Van Rijssen E, Hilbrands LB, Joosten I,. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. Blood 2006: 107: 1018-1023. (Pubitemid 43156300)
34. Battaglia M, Stabilini A, Draghici E, et al., Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 2006: 55: 40-49. (Pubitemid 43343297)
35. Shibutani S, Inoue F, Aramaki O, et al., Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen. Transplantation 2005: 79: 904-913. (Pubitemid 40586862)
36. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D,. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004: 41: 31-37. (Pubitemid 39005149)
37. Mieli-Vergani G, Heller S, Jara P, et al., Autoimmune hepatitis. J Pediatr Gastroenterol Nutr 2009: 49: 158-164.